|
Note 10 — Share-based compensation
The following table shows the total share-based compensation expense included in the unaudited consolidated statements of operations (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Six months ended |
|
|
|
|
June 30, |
|
June 30, |
|
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
|
|
Research and development |
|
$ |
929 |
|
$ |
786 |
|
$ |
1,907 |
|
$ |
2,807 |
|
|
General and administrative |
|
|
1,695 |
|
|
2,410 |
|
|
2,165 |
|
|
3,868 |
|
|
|
|
$ |
2,624 |
|
$ |
3,196 |
|
$ |
4,072 |
|
$ |
6,675 |
|
|
The following table shows information about share options and options which have a nominal exercise price (similar to restricted stock units (RSUs)) granted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Six months ended |
|
|
|
June 30, |
|
June 30, |
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
|
Number of options over ordinary shares granted |
|
|
2,738,936 |
|
|
936,696 |
|
|
12,968,216 |
|
|
11,743,896 |
|
Weighted average fair value of ordinary shares options |
|
$ |
0.30 |
|
$ |
0.39 |
|
$ |
0.47 |
|
$ |
0.54 |
|
Number of additional options with a nominal exercise price granted |
|
|
778,120 |
|
|
459,240 |
|
|
6,838,816 |
|
|
6,957,366 |
|
Weighted average fair value of options with a nominal exercise price |
|
$ |
0.43 |
|
|
0.70 |
|
$ |
0.71 |
|
$ |
0.93 |
|
|